Hu Xueliang | Treatment for Infectious Diseases | Best Researcher Award

Published on by Infectious

Ms. Hu Xueliang | Treatment for Infectious Diseases | Best Researcher Award

Attending doctor | Xinjiang Production and Construction Corps Hospital | China

Dr. Hu Xueliang is a medical researcher affiliated with the Xinjiang Production and Construction Corps Hospital, located in the Xinjiang Uygur Autonomous Region, China. He has developed a multidisciplinary academic foundation built upon rigorous medical education and clinical research training, which fuels his pursuit of excellence in scientific inquiry. His educational background includes advanced studies in clinical medicine and infectious diseases, with specialized exposure to epidemiology, antimicrobial resistance, and translational healthcare practices. Professionally, Dr. Hu has accumulated significant experience working in medical and hospital-based research environments where he has contributed to evidence-based clinical investigations, research collaborations, and the analysis of disease patterns. His research interests span infectious diseases, public health, immunopathology, epidemiological modeling, and antimicrobial stewardship, focusing on the development of innovative strategies for the prevention and control of emerging infectious threats. Dr. Hu demonstrates strong research skills in data collection, statistical evaluation, clinical interpretation, and collaborative project leadership, reflecting a growing engagement in translational research that bridges clinical medicine and public health outcomes. Throughout his developing career, he has earned recognition for his dedication and academic integrity, receiving institutional appreciation and professional commendations for research excellence and medical service. His academic achievements and contributions position him as an emerging scholar within the global medical research community, demonstrating both promise and perseverance. Dr. Hu continues to pursue knowledge dissemination through publications, scientific participation, and health advocacy aimed at improving patient outcomes and public safety. He envisions building a strong research portfolio in infectious disease diagnostics and evidence-based medicine while strengthening global collaboration in health sciences.his current publication metrics indicate 0 Citations  and 1 Document with 0 h-index, reflecting his early-career status and future potential for academic growth.

Profiles : Scopus 

Featured Publications

Hu, X., Guo, X., Sha, J., Dou, Y., Ma, H., Li, H., & Xu, Y. (2025). Analysis of the efficacy of photodynamic therapy in treating cervical lesions and HPV infections and its influencing factors. Photodiagnosis and Photodynamic Therapy, 55, 104786.

Xiaoxiao Liu | Immunology of Infections | Excellence in Innovation

Published on by Infectious

Assoc. Prof. Dr. Xiaoxiao Liu | Immunology of Infections | Excellence in Innovation

Science & Education | Guangdong Provincial People’s Hospital| China

Xiaoxiao Liu, Ph.D., focuses on the interplay between bacteria and bacteriophages, with a particular emphasis on the regulatory mechanisms of bacterial biofilms and prophage activation. Her research addresses critical challenges in combating antibiotic-resistant infections, where biofilms serve as physical barriers that protect bacterial communities and facilitate horizontal gene transfer. Xiaoxiao Liu has systematically elucidated the signaling pathways linking environmental cues, such as low-temperature stress, to host H-NS proteins, resulting in precise prophage activation. This work has advanced the understanding of how prophages influence population-level bacterial adaptation and biofilm dynamics. She has further explored the coupling between prophage activation and biofilm formation, revealing how bacterial populations deploy sophisticated defense strategies to resist phage infection. Xiaoxiao Liu’s research also identifies strategies for enhancing the efficacy of phage therapy, demonstrating how bacterial responses to nutrient limitations, particularly nitrogen starvation, regulate key metabolic targets such as GlnA to control biofilm dispersal. Her work offers novel approaches for disrupting biofilms using targeted metabolites, including arginine, to improve phage penetration and antibacterial outcomes. Current investigations expand on the mechanisms by which bacteria employ defense systems derived from prophages to selectively neutralize diverse phages, providing insights essential for the rational design of engineered phages. By integrating molecular microbiology, biofilm physiology, and phage biology, Xiaoxiao Liu’s research contributes foundational knowledge to the development of innovative antibacterial therapies, emphasizing both fundamental and translational aspects of microbial ecology, phage-bacteria interactions, and biofilm modulation. Her studies have implications for designing more effective phage-based treatments against persistent bacterial infections and enhancing the understanding of microbial population dynamics under environmental stress. 2,901 Citations, 26 Documents, 18 h-index.

Profiles : Scopus

Featured Publications

  1. Author(s). (2026). The diagnostic value of combined detection of GBP1, IFN-γ and IL-2 in differentiating NTM from TB infection. Clinica Chimica Acta.

  2. Author(s). (2024). Control of lysogeny and antiphage defense by a prophage-encoded kinase-phosphatase module. Nature Communications. 10 citations.